| dc.relation | Bacon JL. The Menopausal Transition. Obstet Gynecol Clin North Am. 2017;44(2):285-296. doi: 10.1016/j.ogc.2017 2. Chen R, Yan J, Liu P, Wang Z, Wang C. Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke. Metab Brain Dis. 2017;32(3):667-673. doi: 10.1007/s11011-017-0007-3. 3. Cífková R, Krajčoviechová A. Dyslipidemia and cardiovascular disease in women. Curr Cardiol Rep. 2015;17(7):609. doi: 10.1007/s11886-015-0609-5. 4. Dessapt AL, Gourdy P. Menopause and cardiovascular risk. J Gynecol Obstet Biol Reprod (Paris). 2012;41(7 Suppl):F13-9. doi: 10.1016/j.jgyn.2012.09.006. 5. Rayburn WF, Tracy EE. Changes in the Practice of Obstetrics and Gynecology. Obstet Gynecol Surv. 2016;71(1):43-50. doi: 10.1097/OGX.0000000000000264. 6. Sung SH, Sung AD, Sung HK, An TE, Kim KH, Park JK. Acupuncture Treatment for Chronic Pelvic Pain in Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 2018;2018:9415897. doi: 10.1155/2018/9415897. 7. Woo HL, Ji HR, Pak YK, Lee H, Heo SJ, Lee JM, Park KS. The efficacy and safety of acupuncture in women with primary dysmenorrhea: A systematic review and meta-analysis. Medicine (Baltimore). 2018;97(23):e11007. doi: 10.1097/MD.0000000000011007. 8. Yu SG, Jing XH, Tang Y, Wu QF, Yin HY, Xie LS, Zhao N, Lin SR, Chai XN. Acupuncture and moxibustion and immunity: the actuality and future. Zhen Ci Yan Jiu. 2018;43(12):747-53. doi: 10.13702/j.1000-0607.180623. 9. Li F, He T, Xu Q, Lin LT, Li H, Liu Y, Shi GX, Liu CZ. What is the Acupoint? A preliminary review of Acupoints.Pain Med. 2015;16(10):1905-15. doi: 10.1111/pme.12761. 10. Harding C, Harris A, Chadwick D. Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer. BJU Int. 2009;103(2):186-90. doi: 10.1111/j.1464-410X.2008.07884.x. 11. Lujan-Barroso L, Gibert K, Obón-Santacana M, Chirlaque MD, Sánchez MJ, Larrañaga N, Barricarte A, Quirós JR, Salamanca-Fernández E, Colorado-Yohar S, Gómez-Pozo B, Agudo A, Duell EJ. The influence of lifestyle, diet, and reproductive history on age at natural menopause in Spain: Analysis from the EPIC-Spain sub-cohort. Am J Hum Biol. 2018;30(6):e23181. doi: 10.1002/ajhb.23181. 12. Roman Lay AA, do Nascimento CF, de Oliveira Duarte YA, Porto Chiavegatto Filho AD. Age at natural menopause and mortality: A survival analysis of elderly residents of São Paulo, Brazil. Maturitas. 2018;117:29-33. doi: 10.1016/j.maturitas.2018.08.012 13. Golshiri P, Akbari M, Abdollahzadeh MR. Age at Natural Menopause and Related Factors in Isfahan, Iran. J Menopausal Med. 2016;22(2):87-93. doi: 10.6118/jmm.2016.22.2.87. 14. Andarini S, Sujarwoto S. Early menarche and premature natural menopause in Indonesia. Ann Hum Biol. 2018;45(5):419-427. doi: 10.1080/03014460.2018.1523461. 15. Wang Q, Ferreira DLS, Nelson SM, Sattar N, Ala-Korpela M, Lawlor DA. Metabolic characterization of menopause: cross-sectional and longitudinal evidence. BMC Med. 2018;16(1):17. doi: 10.1186/s12916-018-1008-8. 16. Veening JG, Barendregt HP. The effects of beta-endorphin: state change modification. Fluids Barriers CNS. 2015;12:3. doi: 10.1186/2045-8118-12-3. 17. Mayor DF. Electroacupuncture parameters and beta-endorphin revisited. Acupunct Med. 2008;26(3):197-8. doi: 10.1136/aim.26.3.197 18. Zhang F, Feng Y, Zhou R, Zhang YQ, Chen BY. Observation on the central afferent pathway of "Guanyuan" (CV 4) under normal and pathological states and the influence of electroacupuncture. Zhen Ci Yan Jiu. 2008;33(3):147-53. 19. Timby E, Bäckström T, Nyberg S, Stenlund H, Wihlbäck AN, Bixo M. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study. Psychopharmacology (Berl). 2016;233(11):2109-2117. doi: 10.1007/s00213-016-4258-1. 20. Kim SK, Park JH, Bae SJ, Kim JH, Hwang BG, Min BI, Park DS, Na HS. Effects of electroacupuncture on cold allodynia in a rat model of neuropathic pain: mediation by spinal adrenergic and serotonergic receptors. Exp Neurol. 2005;195(2):430-6. doi: 10.1016/j.expneurol.2005.06.018 | |
